2018
DOI: 10.1111/obr.12674
|View full text |Cite
|
Sign up to set email alerts
|

Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise

Abstract: Independently evaluating changes in glucose metabolism near the time of prostate cancer diagnosis and during long-term ADT treatment is important to distinguish their unique contributions to the development of metabolic disturbances. Integrative approaches, including metabolic, clinical and body composition measures, are needed to understand the role of adiposity and insulin resistance in prostate cancer and to develop effective nutrition and exercise interventions to improve secondary diseases in survivorship. Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
36
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(37 citation statements)
references
References 104 publications
1
36
0
Order By: Relevance
“…The prevalence of prostate cancer in men might be higher in Western countries due to being a comorbidity to obesity-related diseases like insulin resistance and constant inflammation [ 27 , 28 , 29 , 30 ]. Inflammatory signals in the prostate will enhance proliferation of otherwise normal epithelial cells [ 31 ], which could be a starting point for cancer development.…”
Section: Introductionmentioning
confidence: 99%
“…The prevalence of prostate cancer in men might be higher in Western countries due to being a comorbidity to obesity-related diseases like insulin resistance and constant inflammation [ 27 , 28 , 29 , 30 ]. Inflammatory signals in the prostate will enhance proliferation of otherwise normal epithelial cells [ 31 ], which could be a starting point for cancer development.…”
Section: Introductionmentioning
confidence: 99%
“…These real-time PCR data indicate that, for investigating HIF1A pathways in vitro , PC3 cells could serve as an appropriate model ( Table 4 ). Patients with Type 2 diabetes develop more aggressive PCa [ 33 , 34 ] and show increased risk of PCa mortality [ 35 ]; therefore, altered glucose metabolism and the upregulation of glucose transporters could be involved in the progression of PCa in patients with diabetes [ 7 , 24 ]. HPEC cells had high GLUT1 expression levels, whereas CWR-R1ca cells showed the highest expression for GLUT12 transcripts, indicating that these cell lines could be used to analyze the involvement of glucose metabolism in cancer progression.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, paracrine factors secreted by PCa cells were shown to stimulate osteoblasts, which led to excess bone formation [ 6 ]. Metabolic alterations, including obesity, metabolic syndrome, insulin resistance, and diabetes, are known to exacerbate PCa [ 7 , 8 ]. These conditions mediate the aggressivity of PCa via endocrine signaling [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…The relationship between sun exposure and obesity has not been explored in cancer patients. Individuals with breast or prostate cancer are at increased risk of developing obesity, compared to the general population . This may be caused by the modes of action of some cancer treatments, such as chemotherapy, surgery and radiotherapy for breast cancer and hormonal treatments in both breast and prostate cancer .…”
Section: Introductionmentioning
confidence: 99%